IBDEI0O9 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11330,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11330,1,3,0)
 ;;=3^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,11330,1,4,0)
 ;;=4^N39.41
 ;;^UTILITY(U,$J,358.3,11330,2)
 ;;=Urinary Incontinence,Urge^5015680
 ;;^UTILITY(U,$J,358.3,11331,0)
 ;;=R33.0^^47^530^100
 ;;^UTILITY(U,$J,358.3,11331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11331,1,3,0)
 ;;=3^Urinary Retention,Drug-Induced
 ;;^UTILITY(U,$J,358.3,11331,1,4,0)
 ;;=4^R33.0
 ;;^UTILITY(U,$J,358.3,11331,2)
 ;;=^5019330
 ;;^UTILITY(U,$J,358.3,11332,0)
 ;;=R33.9^^47^530^101
 ;;^UTILITY(U,$J,358.3,11332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11332,1,3,0)
 ;;=3^Urinary Retention,Unspec
 ;;^UTILITY(U,$J,358.3,11332,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,11332,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,11333,0)
 ;;=R39.12^^47^530^102
 ;;^UTILITY(U,$J,358.3,11333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11333,1,3,0)
 ;;=3^Urinary Stream,Poor
 ;;^UTILITY(U,$J,358.3,11333,1,4,0)
 ;;=4^R39.12
 ;;^UTILITY(U,$J,358.3,11333,2)
 ;;=^5019342
 ;;^UTILITY(U,$J,358.3,11334,0)
 ;;=R39.13^^47^530^103
 ;;^UTILITY(U,$J,358.3,11334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11334,1,3,0)
 ;;=3^Urinary Stream,Splitting
 ;;^UTILITY(U,$J,358.3,11334,1,4,0)
 ;;=4^R39.13
 ;;^UTILITY(U,$J,358.3,11334,2)
 ;;=^5019343
 ;;^UTILITY(U,$J,358.3,11335,0)
 ;;=N39.9^^47^530^104
 ;;^UTILITY(U,$J,358.3,11335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11335,1,3,0)
 ;;=3^Urinary System Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,11335,1,4,0)
 ;;=4^N39.9
 ;;^UTILITY(U,$J,358.3,11335,2)
 ;;=^5015688
 ;;^UTILITY(U,$J,358.3,11336,0)
 ;;=N39.0^^47^530^80
 ;;^UTILITY(U,$J,358.3,11336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11336,1,3,0)
 ;;=3^UTI,Site not Specified
 ;;^UTILITY(U,$J,358.3,11336,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,11336,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,11337,0)
 ;;=Z87.440^^47^530^57
 ;;^UTILITY(U,$J,358.3,11337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11337,1,3,0)
 ;;=3^Personal Hx of UTI
 ;;^UTILITY(U,$J,358.3,11337,1,4,0)
 ;;=4^Z87.440
 ;;^UTILITY(U,$J,358.3,11337,2)
 ;;=^5063495
 ;;^UTILITY(U,$J,358.3,11338,0)
 ;;=R39.15^^47^530^105
 ;;^UTILITY(U,$J,358.3,11338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11338,1,3,0)
 ;;=3^Urinary Urgency
 ;;^UTILITY(U,$J,358.3,11338,1,4,0)
 ;;=4^R39.15
 ;;^UTILITY(U,$J,358.3,11338,2)
 ;;=^5019345
 ;;^UTILITY(U,$J,358.3,11339,0)
 ;;=R39.0^^47^530^87
 ;;^UTILITY(U,$J,358.3,11339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11339,1,3,0)
 ;;=3^Urinary Extravasation
 ;;^UTILITY(U,$J,358.3,11339,1,4,0)
 ;;=4^R39.0
 ;;^UTILITY(U,$J,358.3,11339,2)
 ;;=^5019340
 ;;^UTILITY(U,$J,358.3,11340,0)
 ;;=N93.9^^47^530^81
 ;;^UTILITY(U,$J,358.3,11340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11340,1,3,0)
 ;;=3^Uerine/Vaginal Bleeding,Abnormal,Unspec
 ;;^UTILITY(U,$J,358.3,11340,1,4,0)
 ;;=4^N93.9
 ;;^UTILITY(U,$J,358.3,11340,2)
 ;;=^5015916
 ;;^UTILITY(U,$J,358.3,11341,0)
 ;;=N85.9^^47^530^107
 ;;^UTILITY(U,$J,358.3,11341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11341,1,3,0)
 ;;=3^Uterus Noninflammatory Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,11341,1,4,0)
 ;;=4^N85.9
 ;;^UTILITY(U,$J,358.3,11341,2)
 ;;=^5015873
 ;;^UTILITY(U,$J,358.3,11342,0)
 ;;=N71.9^^47^530^106
 ;;^UTILITY(U,$J,358.3,11342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11342,1,3,0)
 ;;=3^Uterus Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,11342,1,4,0)
 ;;=4^N71.9
 ;;^UTILITY(U,$J,358.3,11342,2)
 ;;=^5015811
 ;;^UTILITY(U,$J,358.3,11343,0)
 ;;=N76.89^^47^530^109
 ;;^UTILITY(U,$J,358.3,11343,1,0)
 ;;=^358.31IA^4^2
